Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,271 shares at $489.46 ($1.6M) on 2026-02-17, disclosed to the SEC on 2026-02-19.
Seasonal sale ($1.6M) by EVP, Chief Reg. & Quality Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.75 | 2,294 | $1.1M | 70.1% |
| 2 | $489.46 | 609 | $298K | 18.8% |
| 3 | $473.68 | 368 | $174K | 11.0% |
| Total | $483.68 avg | 3,271 | $1.6M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |
| VRTX | SELL | 2026-01-09 | $2.1M | — | Filing → |